A detailed history of Accel Wealth Management transactions in Johnson & Johnson stock. As of the latest transaction made, Accel Wealth Management holds 5,070 shares of JNJ stock, worth $835,637. This represents 0.3% of its overall portfolio holdings.

Number of Shares
5,070
Previous 5,004 1.32%
Holding current value
$835,637
Previous $791,000 6.32%
% of portfolio
0.3%
Previous 0.34%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$144.38 - $157.78 $9,529 - $10,413
66 Added 1.32%
5,070 $741,000
Q1 2024

Apr 19, 2024

BUY
$155.22 - $162.74 $166,240 - $174,294
1,071 Added 27.23%
5,004 $791,000
Q4 2023

Jan 18, 2024

BUY
$145.6 - $158.88 $11,939 - $13,028
82 Added 2.13%
3,933 $616,000
Q3 2023

Oct 19, 2023

SELL
$155.75 - $174.48 $24,452 - $27,393
-157 Reduced 3.92%
3,851 $599,000
Q2 2023

Jul 24, 2023

BUY
$154.35 - $166.11 $24,232 - $26,079
157 Added 4.08%
4,008 $663,000
Q1 2023

Apr 20, 2023

BUY
$151.05 - $180.26 $39,273 - $46,867
260 Added 7.24%
3,851 $596,000
Q4 2022

Jan 26, 2023

BUY
$160.2 - $179.79 $12,335 - $13,843
77 Added 2.19%
3,591 $0
Q3 2022

Oct 12, 2022

SELL
$161.33 - $179.52 $134,226 - $149,360
-832 Reduced 19.14%
3,514 $582,000
Q2 2022

Aug 03, 2022

BUY
$168.19 - $186.01 $2,691 - $2,976
16 Added 0.37%
4,346 $775,000
Q1 2022

Apr 29, 2022

BUY
$158.14 - $179.59 $13,441 - $15,265
85 Added 2.0%
4,330 $771,000
Q4 2021

Jan 18, 2022

BUY
$155.93 - $173.01 $109,618 - $121,626
703 Added 19.85%
4,245 $726,000
Q3 2021

Nov 04, 2021

BUY
$161.5 - $179.47 $1,453 - $1,615
9 Added 0.25%
3,542 $572,000
Q2 2021

Aug 03, 2021

SELL
$159.48 - $171.07 $187,389 - $201,007
-1,175 Reduced 24.96%
3,533 $582,000
Q1 2021

May 10, 2021

SELL
$153.07 - $170.48 $83,117 - $92,570
-543 Reduced 10.34%
4,708 $774,000
Q4 2020

Jan 27, 2021

BUY
$137.11 - $157.38 $719,964 - $826,402
5,251 New
5,251 $827,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $431B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Accel Wealth Management Portfolio

Follow Accel Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Accel Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Accel Wealth Management with notifications on news.